Editorial: Natural products as drivers in drug development for neurodegenerative disorders, volume II

Joana Silva; Rebeca Alvariño; Márcia I Goettert; Hector J Caruncho; Celso Alves

doi:10.3389/fphar.2023.1329769

Editorial: Natural products as drivers in drug development for neurodegenerative disorders, volume II

Front Pharmacol. 2023 Nov 17:14:1329769. doi: 10.3389/fphar.2023.1329769. eCollection 2023.

Authors

Joana Silva¹, Rebeca Alvariño², Márcia I Goettert³, Hector J Caruncho⁴, Celso Alves¹

Affiliations

¹ MARE-Marine and Environmental Sciences Centre/ARNET, ESTM (School of Tourism and Maritime Technology), Polytechnic University of Leiria, Peniche, Portugal.
² Department of Pharmacology, Faculty of Veterinary, University of Santiago de Compostela, Lugo, Spain.
³ Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Eberhard Karls Universität Tübingen, Tübingen, Germany.
⁴ Division of Medical Sciences, University of Victoria, Victoria, BC, Canada.

No abstract available

Keywords: drug discovery; ethnopharmacology; mechanisms of action; natural products; neuroinflammation; neuropharmacology; oxidative stress.

Publication types

Editorial

Grants and funding

The authors declare financial support was received for the research, authorship, and/or publication of this article. CA acknowledges the support by the Portuguese Foundation for Science and Technology (FCT) through the strategic projects granted to MARE—Marine and Environmental Sciences Centre (UIDP/04292/2020 and UIDB/04292/2020) and Associate Laboratory ARNET (LA/P/0069/2020). This work was also supported by the FCT and CAPES cooperation agreement through project MArTics (FCT/DRI/CAPES 2019.00277. CBM).